Elekta, a market leader in radiotherapy, is set to outgrow the industry in the mid-term – driven by potential pick-up in demand for its new linac (Unity) and expected orders from China. Moreover, with robust margin expansion potential – led by an increasing proportion of Unity and software/service revenue and targeted cost-savings – earnings should grow healthily. Throw on top a sturdy balance sheet and a consistently-increasing dividend flow, Elekta is attractive at current
13 Jan 2020
Banking on Unity and China's orders
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Banking on Unity and China's orders
Elekta AB Class B (EJXB:FRA) | 0 0 0.5% | Mkt Cap: 27,040m
- Published:
13 Jan 2020 -
Author:
Sumit Sayal -
Pages:
4
Elekta, a market leader in radiotherapy, is set to outgrow the industry in the mid-term – driven by potential pick-up in demand for its new linac (Unity) and expected orders from China. Moreover, with robust margin expansion potential – led by an increasing proportion of Unity and software/service revenue and targeted cost-savings – earnings should grow healthily. Throw on top a sturdy balance sheet and a consistently-increasing dividend flow, Elekta is attractive at current